Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid
1Intervention Section, Department of Cell and Cancer Biology, Division of Clinical Sciences, National Cancer Institute, NIH Clinical Center, 9000 Rockville Pike, Bethesda, MD 20892-1906, USA.
Abstract:
Many arachidonic acid metabolites function in growth signaling for epithelial cells, and we previously reported the expression of the major arachidonic acid enzymes in human breast cancer cell lines. To evaluate the role of the 5-lipoxygenase (5-LO) pathway on breast cancer growth regulation, we exposed cells to insulinlike growth factor-1 or transferrin, which increased the levels of the 5-LO metabolite, 5(S)-hydrooxyeicosa-6E,8C,11Z,14Z-tetraenoic acid (5-HETE), by radioimmunoassay and high-performance liquid chromatography. Addition of 5-HETE to breast cancer cells resulted in growth stimulation, whereas selective biochemical inhibitors of 5-LO reduced the levels of 5-HETE and related metabolites. Application of 5-LO or 5-LO activating protein-directed inhibitors, but not a cyclooxygenase inhibitor, reduced growth, increased apoptosis, down-regulated bcl-2, up-regulated bax, and increased G1 arrest. Exposure of breast cancer cells to a 5-LO inhibitor up-regulated peroxisome proliferator-activated receptor (PPAR)a and PPARg expression, and these same cells were growth inhibited when exposed to relevant PPAR agonists. These results suggest that disruption of the 5-LO signaling pathway mediates growth arrest and apoptosis in breast cancer cells. Additional experiments suggest that this involves the interplay of several factors, including the loss of growth stimulation by 5-LO products, the induction of PPARg, and the potential activation of PPARg by interactions with shunted endoperoxides.
Insights
Inhibiting the 5-lipoxygenase (5-LO) pathway halts breast cancer cell growth and promotes apoptosis. This disruption impacts key proteins and activates specific receptors, offering a new therapeutic target.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Arachidonic acid metabolites are crucial for epithelial cell growth signaling.
- Previous studies identified arachidonic acid enzymes in human breast cancer cell lines.
Purpose of the Study:
- To investigate the role of the 5-lipoxygenase (5-LO) pathway in regulating breast cancer cell growth.
- To determine the effects of 5-LO pathway modulation on cancer cell proliferation and apoptosis.
Main Methods:
- Human breast cancer cell lines were treated with growth factors (IGF-1, transferrin) to modulate 5-LO metabolite levels.
- Radioimmunoassay and HPLC were used to quantify 5-HETE levels.
- Cells were treated with 5-LO inhibitors, PPAR agonists, and cyclooxygenase inhibitors.
Main Results:
- Insulin-like growth factor-1 and transferrin increased 5-lipoxygenase metabolite 5(S)-hydrooxyeicosa-6E,8C,11Z,14Z-tetraenoic acid (5-HETE) levels.
- 5-HETE addition stimulated breast cancer cell growth; 5-LO inhibitors reduced 5-HETE, inhibited growth, and increased apoptosis.
- 5-LO inhibition led to G1 arrest, altered bcl-2 and bax expression, and upregulated PPARa and PPARg.
Conclusions:
- Disrupting the 5-LO signaling pathway induces growth arrest and apoptosis in breast cancer cells.
- This process involves reduced 5-LO product stimulation and induced PPARg expression.
- Potential activation of PPARg by shunted endoperoxides may contribute to therapeutic effects.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...


